BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 30575821)

  • 1. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
    Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent
    Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
    Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Heterogeneity of Pediatric AML with Atypical Promyelocytes Accumulation in Children-A Single Center Experience.
    Borkovskaia A; Bogacheva S; Konyukhova T; Dadakhanova E; Gaskova M; Soldatkina O; Dubrovina M; Popov A; Mikhailova E; Inushkina E; Kazanov M; Matveev E; Novichkova G; Maschan M; Maschan A; Olshanskaya Y; Zerkalenkova E
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
    Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
    Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RARA fluorescence in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemia.
    Lee DS; Lee YS; Kim YR; Han KS; Park KU; She CJ; Kim EC; Park SY; Cho HI
    Cancer Genet Cytogenet; 2002 Dec; 139(2):104-8. PubMed ID: 12550769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion.
    Kirkham JK; Liu YC; Foy SG; Ma J; Gheorghe G; Furtado LV; Popescu MI; Klco JM; Karol SE; Blackburn PR
    Genes Chromosomes Cancer; 2023 Oct; 62(10):617-623. PubMed ID: 37283355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia.
    Coccaro N; Zagaria A; Orsini P; Anelli L; Tota G; Casieri P; Impera L; Minervini A; Minervini CF; Cumbo C; Parciante E; Mestice A; Delia M; Brunetti C; Specchia G; Albano F
    Hum Pathol; 2018 Oct; 80():82-86. PubMed ID: 29530751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short report of novel
    Song Y; Hou J; Wan L; Liu K; Zhou C; Wei S; Zhang G; Lin D; Li Y; Fang Q; Liu Y; Gong B; Gong X; Wang Y; Wei H; Wang J; Mi Y
    Hematology; 2022 Dec; 27(1):518-522. PubMed ID: 35544458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia.
    Borrow J; Solomon E
    Baillieres Clin Haematol; 1992 Oct; 5(4):833-56. PubMed ID: 1339190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia.
    Albano F; Zagaria A; Anelli L; Coccaro N; Tota G; Brunetti C; Minervini CF; Impera L; Minervini A; Cellamare A; Orsini P; Cumbo C; Casieri P; Specchia G
    Oncotarget; 2015 May; 6(15):13269-77. PubMed ID: 25944686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.
    Sainty D; Liso V; Cantù-Rajnoldi A; Head D; Mozziconacci MJ; Arnoulet C; Benattar L; Fenu S; Mancini M; Duchayne E; Mahon FX; Gutierrez N; Birg F; Biondi A; Grimwade D; Lafage-Pochitaloff M; Hagemeijer A; Flandrin G; ; ; ;
    Blood; 2000 Aug; 96(4):1287-96. PubMed ID: 10942370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting.
    Nasr R; de Thé H
    Int J Hematol; 2010 Jun; 91(5):742-7. PubMed ID: 20455087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
    Lang L; Li HM; Liu H; Wang YM; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).
    Hirade K; Kusumoto S; Abe A; Noritake H; Ito A; Ri M; Komatsu H; Iida S; Yamamoto Y
    Int J Hematol; 2022 Dec; 116(6):956-960. PubMed ID: 35854096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pathogenic NRAS c.38G>A (p.G13D) Mutation in RARA Translocation-negative Acute Promyelocytic-like Leukemia with Concomitant Myelodysplastic Syndrome.
    Goto H; Yakushijin K; Adachi Y; Matsumoto H; Yamamoto K; Matsumoto S; Yamashita T; Higashime A; Kawaguchi K; Kurata K; Matsuoka H; Minami H
    Intern Med; 2023 May; 62(9):1329-1334. PubMed ID: 36130886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
    Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
    Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia.
    Turhan AG; Lemoine FM; Debert C; Bonnet ML; Baillou C; Picard F; Macintyre EA; Varet B
    Blood; 1995 Apr; 85(8):2154-61. PubMed ID: 7536493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia.
    Yin CC; Jain N; Mehrotra M; Zhagn J; Protopopov A; Zuo Z; Pemmaraju N; DiNardo C; Hirsch-Ginsberg C; Wang SA; Medeiros LJ; Chin L; Patel KP; Ravandi F; Futreal A; Bueso-Ramos CE
    J Natl Compr Canc Netw; 2015 Jan; 13(1):19-22. PubMed ID: 25583766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.